Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA page revision identifier was updated from **v3.5.2** to **v3.5.3**, reflecting an update to the site/version rather than any change to the clinical trial information.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe site revision has been updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.2 was added and the funding/operating status notice (v3.4.1) was removed, with no changes to study data; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedNotice added about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to check cc.nih.gov and opm.gov. Revision history updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.